RecruitingNCT06774677

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

50 participants

Start Date

Dec 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a national multi-centre, experimental, cross-sectional, non-profit study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating hairy cell leukemia (HCL), a rare type of blood cancer, by studying tiny particles called extracellular vesicles — small packages that cells release to communicate with each other. Researchers want to understand how cancer cells use these signals to survive and grow, with the goal of finding better treatments. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with hairy cell leukemia (as defined by WHO 2022 criteria) - You are willing to sign informed consent - (Healthy volunteers are also eligible: adults aged 18+ in good general health) **You may NOT be eligible if...** - There are no specific exclusion criteria listed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello

Palermo, PA, Italy

Policlinico Santa Maria alla Scotte

Siena, SI, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06774677


Related Trials